Font: Financial Modeling Prep • Apr 01, 2026
RH (NYSE: RH) reported fourth-quarter results that missed analyst expectations, sending shares down more than 22% intraday Wednesday.
The luxury home furnishings retailer posted adjusted earnings per share of $1.53, falling short of the $2.22 consensus estimate by $0.69. Revenue totaled $842.6 million, below the expected $873.48 million, though it increased 3.7% from the prior-year period.
The company said fourth-quarter and full-year 2025 results were negatively impacted by approximately $30 million due to higher-than-anticipated backorders and special order balances tied to tariff-related sourcing challenges, as well as about $10 million in weather-related disruptions at the end of the quarter.
Looking ahead, RH’s first-quarter fiscal 2026 guidance disappointed investors, with revenue projected to decline between 2% and 4% and adjusted EBITDA margin expected in the range of 5.5% to 6.5%.
For the full fiscal year 2025, RH reported net revenue of $3.44 billion, up 8.1% year over year, while GAAP net income increased 72% to $125 million. The company also generated $252 million in free cash flow during the year.
For fiscal 2026, RH forecast revenue growth of 4% to 8%, with a midpoint of 6% that it described as conservative. The company expects adjusted EBITDA margins between 14% and 16% and adjusted free cash flow of $300 million to $400 million. The outlook includes an estimated 270 basis point headwind to adjusted EBITDA margin from pre-opening and startup expenses associated with international expansion efforts.
|
GV§>
Visionary Holdings Inc.
|
$0.44
116.78%
|
|
LNKS§>
Linkers Industries Limited
|
$0.01
-35.16%
|
|
AIXI§>
Xiao-I Corporation
|
$0.13
33.10%
|
|
SKYQ§>
Sky Quarry Inc.
|
$5.10
101.58%
|
|
NVDA§>
NVIDIA Corporation
|
$177.39
0.93%
|
|
BITO§>
ProShares - Bitcoin ETF
|
$9.21
-1.60%
|
|
COCP§>
Cocrystal Pharma, Inc.
|
$1.51
48.04%
|
|
TSLL§>
Direxion Daily TSLA Bull 2X ETF
|
$11.37
-10.96%
|
|
SPDN§>
Direxion Daily S&P 500 Bear 1X ETF
|
$9.87
0.10%
|
|
BDRX§>
Biodexa Pharmaceuticals Plc
|
$0.87
42.23%
|